en · de · es · fr · pt
faq-desk.peptides1004.com › Topic › Background And Molecular Identity — Evidence Review

Background And Molecular Identity — Evidence Review

By Editorial Desk · published 2025-07-01 · last reviewed 2025-07-17 · Topic

A practical reference on lyophilized powder: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-07-17 and is reviewed periodically as new material appears.

Background and Molecular Identity

The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.

Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.

Handling And Analytical Properties

Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.

AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.

Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.

Aod-9604 at a glance

PropertyValueNotes
Molecular classSynthetic peptideBased on the C-terminal region of human growth hormone.
Amino acid length16 residuesOften described as hGH fragment 176-191.
AppearanceLyophilized powderTypically white to off-white; exact appearance depends on grade.
SolubilitySoluble in waterAqueous solubility depends on pH, ionic strength, and preparation.
Typical storage-20 °C or lowerLyophilized peptide is usually kept cold and dry; solutions may require freezing.

Handling, Analysis, and Quality Control

Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.

Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.

Related pages on this site

Regulation and Detection Context

Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.

AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.

Notes from published material

=== Medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency === Medium-chain acyl-coenzyme A dehydrogenase (MCAD) deficiency is the most common fatty acid β-oxidation disorder and a prevalent metabolic congenital error It is often identified through newborn screening. Although children are normal at birth, symptoms usually emerge between three months and two years of age, with some cases appearing in adulthood. Medium-chain acyl-CoA dehydrogenase (MCAD) plays a crucial role in mitochondrial fatty acid β-oxidation, a process vital for generating energy during extended fasting or high-energy demand periods. This process, especially important when liver glycogen is depleted, supports hepatic ketogenesis. The specific step catalyzed by MCAD involves the dehydrogenation of acyl-CoA. This step converts medium-chain acyl-CoA to trans-2-enoyl-CoA, which is then further metabolized to produce energy in the form of ATP. Symptoms

==== Economic issues ==== In 2010, Larson introduced the Small Business Jobs Act of 2010, authorizing the creation of the Small Business Lending Fund Program administered by the Treasury Department to make capital investments in eligible institutions, in order to increase the availability of credit for small businesses. Larson was a strong advocate for the American Recovery and Reinvestment Act of 2009, which increased federal spending in infrastructure, education, health and energy while expanding some welfare and social security programs. His liberal stance on government spending has earned him a rating of 9% with Citizens Against Government Waste, a conservative anti-government spending interest group.

Commercial shrimp farming began in the 1970s, and production grew steeply thereafter. Global production reached more than 1.6 million tonnes in 2003, worth about US$9 billion. About 75% of farmed shrimp is produced in Asia, in particular in China and Thailand. The other 25% is produced mainly in Latin America, where Brazil is the largest producer. Thailand is the largest exporter. Shrimp farming has changed from its traditional, small-scale form in Southeast Asia into a global industry. Technological advances have led to ever higher densities per unit area, and broodstock is shipped worldwide. Virtually all farmed shrimp are penaeids (i.e., shrimp of the family Penaeidae), and just two species of shrimp, the Pacific white shrimp and the giant tiger prawn, account for about 80% of all farmed shrimp. These industrial monocultures are very susceptible to disease, which has decimated shrimp populations across entire regions. Increasing ecological problems, repeated disease outbreaks, and pressure and criticism from both nongovernmental organizations and consumer countries led to changes in the industry in the late 1990s and generally stronger regulations. In 1999, governments, industry representatives, and environmental organizations initiated a program aimed at developing and promoting more sustainable farming practices through the Seafood Watch program. Freshwater prawn farming shares many characteristics with, including many problems with, marine shrimp farming. Unique problems are introduced by the developmental lifecycle of the main species, the giant river prawn.

The Iberian conflict began when Portugal continued trade with Britain, despite French restrictions. When Spain failed to maintain the Continental System, the uneasy Spanish alliance with France ended in all but name. French troops gradually encroached on Spanish territory until they occupied Madrid, and installed a client monarchy. This provoked an explosion of popular rebellions across Spain. Heavy British involvement soon followed. After France suffered defeats in Spain, Napoleon took charge and enjoyed success, retaking Madrid, defeating the Spanish, and forcing a withdrawal of the heavily out-numbered British army from the Iberian Peninsula (Battle of Corunna, 16 January 1809). But when he left, the guerrilla war against his forces in the countryside continued to tie down great numbers of troops. The outbreak of the War of the Fifth Coalition prevented Napoleon from successfully wrapping up operations against British forces by necessitating his departure for Austria, and he never returned to the Peninsular theatre. The British then sent in a fresh army under Sir Arthur Wellesley (later the Duke of Wellington). For a time, the British and Portuguese remained restricted to the area around Lisbon (behind their impregnable Lines of Torres Vedras), while their Spanish allies were besieged in Cádiz. The Peninsular war proved a major disaster for France. Napoleon did well when he was in direct charge, but severe losses followed his departure, as he severely underestimated how much manpower would be needed. The effort in Spain was a drain on money, manpower and prestige.

== M == MACF1 MacMARKS Mena Myopodin MAP1A Merlin (related to the ERM proteins) Myosins MAP-1C Metavinculin Moesin (the M of ERM proteins) Myosin light chain kinase MAL Mip-90 Myosin Light Chain A1 MARKS MIM MAYP Mycalolide (a macroglide drug) Mayven Myelin basic protein

Sources: en.wikipedia.org

Background from the literature

==== Phenylethylamine ==== In general, phenylethylamine consists of an aromatic ring connected to an amine group which is 2 carbons away. Each type of phenylethylamine differs by the substitutions at the alpha and beta carbon position. When a methyl group is attached at the alpha position, the compound becomes amphetamines which has the ability to modulate the 5HT-2A serotonin receptors. Eventually, the activated receptors cause hallucinations. To ensure sufficient binding, the agonists must contain a primary amine, methoxy group and hydrophobic functional groups.

==== Kinases ==== Protein kinases are the enzymes responsible for phosphorylation of serine and threonine residues. O-GlcNAc has been identified on over 100 (~20% of the human kinome) kinases, and this modification is often associated with alterations in kinase activity or kinase substrate scope. O-GlcNAc may have diverse functional consequences on kinases such as interfering with ATP binding, altering substrate recognition, or regulating other PTMs on kinases. Complex cross-talk relations can also exist where OGT and a kinase, e.g., AMPK, modify each other.

===== Alcohol ===== Repeated alcohol exposure alters both DNA methylation and hydroxymethylation of the OPRK1 promoter in the nucleus accumbens, a key reward centre in alcohol-preferring rodent models. Chronic intermittent ethanol exposure reduces both 5-methylcytosine and 5-hydroxymethylcytosine percentages in the OPRK1 promoter, leading to changes in receptor expression correlated with addiction-related motivational and reward behaviours.

== Interactions based on pharmacodynamics == Pharmacodynamic interactions are the drug–drug interactions that occur at a biochemical level and depend mainly on the biological processes of organisms. These interactions occur due to action on the same targets; for example, the same receptor or signaling pathway.

Sources: en.wikipedia.org

Further detail

== Death == He collapsed at his university laboratory bench, having insisted on continuing to work during a heat wave, despite having an influenza-caused high temperature. He died of pneumonia, several days later, at Warringa Private Hospital, in Glenelg, South Australia on 18 January 1930. He was cremated on 20 January 1930, at West Terrace Cemetery, and his ashes were scattered in Waterfall Gully, South Australia.

=== EC 1.14.21 With NADH or NADPH as one donor, and the other dehydrogenated === EC 1.14.21.1: Now EC 1.14.19.64, (S)-stylopine synthase EC 1.14.21.2: Now EC 1.14.19.65, (S)-cheilanthifoline synthase EC 1.14.21.3: Now EC 1.14.19.66, berbamunine synthase EC 1.14.21.4: Now EC 1.14.19.67, salutaridine synthase EC 1.14.21.5: Now EC 1.14.19.68, (S)-canadine synthase EC 1.14.21.6: Now EC 1.14.19.20, Δ7-sterol 5(6)-desaturase EC 1.14.21.7: Now EC 1.14.19.69, biflaviolin synthase EC 1.14.21.8: Now EC 1.14.19.63, pseudobaptigenin synthase EC 1.14.21.9: Now EC 1.14.19.70, mycocyclosin synthase * EC 1.14.21.10: Now EC 1.14.19.71, fumitremorgin C synthase * EC 1.14.21.11: Now EC 1.14.19.72, (–)-pluviatolide synthase * EC 1.14.21.12: Now EC 1.14.19.73, (S)-nandinine synthase *

Mikania micrantha is a widespread weed in the tropics. It grows very quickly (as fast as 80 to 90 millimetres (3.1 to 3.5 in) in 24 hours for a young plant) and covers other plants, shrubs and even trees. Mikania is a problem in Nepal, covering more than 20% of the Chitwan National Park. Various control measures against Mikania have been tried in many countries. It is moderately susceptible to the herbicides 2,4-D and 2,4,5-T and paraquat. Cuscuta, a parasitic plant, has been used in Assam and Sri Lanka to suppress the spread of Mikania from waste land to tea plantations. Other control measures include the rust fungus Puccinia spegazzinii and the thrips species Liothrips mikaniae. An example of its success can be seen in Hong Kong where first recorded in 1884, it has now spread throughout the region and invades its country parks. Economic gains due to Mikania are meager compared to the loss due to its infestation in various ecosystems. It is used as a fodder in many countries. Sheep preferentially grazed Mikania in Malaysia and other cattle also relish it. In Kerala, India, the weed is utilized as a fodder in some parts of the state, especially during summer when the availability of grass is scarce. However, Mikania is known to cause hepatotoxicity and liver damage in dairy cattle. The antibacterial effect of Mikania and its efficacy in wound healing has been reported. In Assam (NE India), Kabi tribes use the leaf juice of Mikania as an antidote for insect bite and scorpion sting. The leaves are also used for treating stomachache.

== Early life, education and career == Roy was born in the Indian state of West Bengal. He completed his schooling at Ballygunge Government High School, then obtained a first class honours degree in chemistry (BSc Hons) from Presidency College, Calcutta in 1974 and did his doctoral studies at the University of Delaware under the guidance of Prof. Roberta F. Colman to secure a PhD in 1981. His post-doctoral studies were at Brandeis University at the laboratory of Prof. Alfred Redfield (1981–82) and at the National Institutes of Health (1982–86). Returning to India in 1986, he joined Bose Institute, Kolkata as a senior lecturer in the department of biophysics. He served the Institute till 2004 holding positions of Reader and then Professor of Biophysics when he moved to the Indian Institute of Chemical Biology (IICB) as its director. After completing 10 years as the director of IICB, he returned to Bose Institute in 2014 as a senior professor and dean of studies. While at IICB, he has served the nation in several different high-level capacities such as the founder-director-in-charge of the National Institute of Pharmaceutical Education and Research, Kolkata (NIPER) (2007–14), the cluster director of 11 Biological institutes of the Council of Scientific and Industrial Research (CSIR) (2009–14), member of the governing body of the CSIR and as a visiting professor at Osaka University (2012). He has served as the president of the West Bengal Academy of Science and Technology. He is the founder-president of the Chemical Biology Society of India.

The city's main opera house is Teatro Regio di Torino, where Puccini premiered his La bohème in 1896. It was burned down in 1936 and was rebuilt after World War II. On 8 October 2021, the European Broadcasting Union (EBU) and RAI announced that the city would host the Eurovision Song Contest 2022, following Italy's victory at the 2021 contest in Rotterdam, Netherlands, with the song "Zitti e buoni", performed by Måneskin. The contest took place at the Pala Alpitour, with both semi-finals of the contest took place on 10 and 12 May, and the grand final on 14 May. It was the first time that Turin has hosted the contest and the third time that Italy has hosted the contest overall, with the last being in Rome in 1991.

Sources: en.wikipedia.org

Frequently asked questions

What is AOD-9604?

It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.

Is AOD-9604 the same as human growth hormone?

No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.

Does AOD-9604 occur naturally?

The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.

How should AOD-9604 be stored?

Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.

Network